New Applications of Photodynamic Therapy in the Management of Candidiasis

Carmen Rodríguez-Cerdeira1,2,3,4,5, Erick Martínez-Herrera1,4,5,6,7, Gabriella Fabbrocini4,8

  • 1Efficiency, Quality and Costs in Health Services Research Group (EFISALUD), Health Research Institute, SERGAS-UVIGO, 36213 Vigo, Spain.

Insights

Photodynamic therapy (PDT) offers a promising alternative to conventional antifungals for treating candidiasis. This approach effectively combats drug-resistant Candida species, showing potential for clinical use.

Area of Science:

  • Mycology
  • Photochemistry
  • Infectious Diseases

Background:

  • Candida species are significant causes of opportunistic mycoses, leading to severe and potentially fatal infections.
  • Candida albicans is frequently isolated and exhibits variable resistance to standard antifungal treatments.
  • Antimicrobial photodynamic therapy (aPDT) is an emerging treatment modality utilizing photosensitizers and light to generate reactive oxygen species for microbial killing.

Purpose of the Study:

  • To systematically review new applications of photodynamic therapy (PDT) in managing candidiasis.
  • To evaluate the effectiveness and safety of aPDT against Candida species, particularly those resistant to conventional antifungals.

Main Methods:

  • A systematic review was conducted, screening 222 studies and including 84 for in-depth analysis.
  • The review focused on studies reporting antifungal effectiveness, toxicity, and dosimetry of aPDT using various photosensitizers against Candida species.

Main Results:

  • All included studies demonstrated the antifungal effectiveness of aPDT against Candida species.
  • aPDT showed superior performance compared to conventional antifungal therapies, especially against resistant strains.
  • Data on toxicity and optimal dosimetry for aPDT were reported across the evaluated studies.

Conclusions:

  • Antimicrobial photodynamic therapy (aPDT) presents a broad range of new applications for managing candidiasis, including infections caused by antifungal-resistant Candida strains.
  • aPDT demonstrates superior efficacy over traditional antifungal treatments.
  • Further research into aPDT is warranted to establish its value in routine clinical practice for candidiasis management.

Related Concept Videos